LRP2 and Crush Syndrome: We investigated whether cilastatin sodium, a megalin inhibitor which is US Food and Drug Administration-approved for another purpose, has efficacy as a crush syndrome treatment in a highly translational large animal trauma model.<h4>Methods</h4>Anesthetized 40 kg female pigs received blunt muscle injury and 48 h protocolized critical care management.